世界の新興癌ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Emerging Cancer Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR09F0989
• 出版社/出版日：GlobalInfoResearch / 2019年11月11日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、123ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、新興癌ワクチンの世界市場について調べ、まとめました。種類別セグメントは、非遺伝子ワクチン、遺伝子ワクチン等、用途別セグメントは、がん研究センター、がん病院、クリニック、その他等に区分しました。新興癌ワクチンの世界市場概観、メーカー動向、メーカー別新興癌ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・新興癌ワクチンの市場概観
・新興癌ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・新興癌ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向
・新興癌ワクチンの世界市場規模
・新興癌ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等）
・新興癌ワクチンのアメリカ市場規模推移
・新興癌ワクチンのカナダ市場規模推移
・新興癌ワクチンのメキシコ市場規模推移
・新興癌ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・新興癌ワクチンのドイツ市場規模推移
・新興癌ワクチンのイギリス市場規模推移
・新興癌ワクチンのロシア市場規模推移
・新興癌ワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・新興癌ワクチンの日本市場規模推移
・新興癌ワクチンの中国市場規模推移
・新興癌ワクチンの韓国市場規模推移
・新興癌ワクチンのインド市場規模推移
・新興癌ワクチンの東南アジア市場規模推移
・新興癌ワクチンの南米市場分析（ブラジル、アルゼンチン等）
・新興癌ワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・新興癌ワクチンの種類別分析/販売量、売上、市場シェア（非遺伝子ワクチン、遺伝子ワクチン）
・新興癌ワクチンの用途別分析/市場規模（がん研究センター、がん病院、クリニック、その他）
・新興癌ワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・新興癌ワクチンの販売チャネル・代理店・貿易業者・ディーラー分析

Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens.

Scope of the Report:
The worldwide market for Emerging Cancer Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Emerging Cancer Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Antigenics
Avax Technologies
GlaxoSmithKline
Merck
Moderna
Northwest Biotherapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Non Genetic Vaccines
Genetic Vaccines

Market Segment by Applications, can be divided into
Cancer Research Centers
Cancer Hospital
Clinics
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Emerging Cancer Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Emerging Cancer Vaccines, with price, sales, revenue and global market share of Emerging Cancer Vaccines in 2017 and 2018.
Chapter 3, the Emerging Cancer Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Emerging Cancer Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Emerging Cancer Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Emerging Cancer Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Emerging Cancer Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Non Genetic Vaccines
1.2.2 Genetic Vaccines
1.3 Market Analysis by Applications
1.3.1 Cancer Research Centers
1.3.2 Cancer Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Antigenics
2.1.1 Business Overview
2.1.2 Emerging Cancer Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Antigenics Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Avax Technologies
2.2.1 Business Overview
2.2.2 Emerging Cancer Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Avax Technologies Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Emerging Cancer Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Emerging Cancer Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Moderna
2.5.1 Business Overview
2.5.2 Emerging Cancer Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Moderna Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Northwest Biotherapeutics
2.6.1 Business Overview
2.6.2 Emerging Cancer Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Northwest Biotherapeutics Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Emerging Cancer Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Emerging Cancer Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Emerging Cancer Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Emerging Cancer Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Emerging Cancer Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Emerging Cancer Vaccines Market Analysis by Regions
4.1 Global Emerging Cancer Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Emerging Cancer Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Emerging Cancer Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
5 North America Emerging Cancer Vaccines by Country
5.1 North America Emerging Cancer Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Emerging Cancer Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Emerging Cancer Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
6 Europe Emerging Cancer Vaccines by Country
6.1 Europe Emerging Cancer Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Emerging Cancer Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Emerging Cancer Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
6.4 France Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Emerging Cancer Vaccines by Country
7.1 Asia-Pacific Emerging Cancer Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Emerging Cancer Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Emerging Cancer Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
7.5 India Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
8 South America Emerging Cancer Vaccines by Country
8.1 South America Emerging Cancer Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Emerging Cancer Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Emerging Cancer Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Emerging Cancer Vaccines by Countries
9.1 Middle East and Africa Emerging Cancer Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Emerging Cancer Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Emerging Cancer Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
10 Global Emerging Cancer Vaccines Market Segment by Type
10.1 Global Emerging Cancer Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Emerging Cancer Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Emerging Cancer Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Non Genetic Vaccines Sales Growth and Price
10.2.1 Global Non Genetic Vaccines Sales Growth (2014-2019)
10.2.2 Global Non Genetic Vaccines Price (2014-2019)
10.3 Genetic Vaccines Sales Growth and Price
10.3.1 Global Genetic Vaccines Sales Growth (2014-2019)
10.3.2 Global Genetic Vaccines Price (2014-2019)
11 Global Emerging Cancer Vaccines Market Segment by Application
11.1 Global Emerging Cancer Vaccines Sales Market Share by Application (2014-2019)
11.2 Cancer Research Centers Sales Growth (2014-2019)
11.3 Cancer Hospital Sales Growth (2014-2019)
11.4 Clinics Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Emerging Cancer Vaccines Market Forecast (2019-2024)
12.1 Global Emerging Cancer Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Emerging Cancer Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Emerging Cancer Vaccines Market Forecast (2019-2024)
12.2.2 Europe Emerging Cancer Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Emerging Cancer Vaccines Market Forecast (2019-2024)
12.2.4 South America Emerging Cancer Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Emerging Cancer Vaccines Market Forecast (2019-2024)
12.3 Emerging Cancer Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Emerging Cancer Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Emerging Cancer Vaccines Market Share Forecast by Type (2019-2024)
12.4 Emerging Cancer Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Emerging Cancer Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Emerging Cancer Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Emerging Cancer Vaccines Picture
Table Product Specifications of Emerging Cancer Vaccines
Figure Global Sales Market Share of Emerging Cancer Vaccines by Types in 2018
Table Emerging Cancer Vaccines Types for Major Manufacturers
Figure Non Genetic Vaccines Picture
Figure Genetic Vaccines Picture
Figure Emerging Cancer Vaccines Sales Market Share by Applications in 2018
Figure Cancer Research Centers Picture
Figure Cancer Hospital Picture
Figure Clinics Picture
Figure Others Picture
Figure United States Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure France Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure UK Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure China Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure India Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Emerging Cancer Vaccines Revenue (Value) and Growth Rate (2014-2024)
Table Antigenics Basic Information, Manufacturing Base and Competitors
Table Antigenics Emerging Cancer Vaccines Type and Applications
Table Antigenics Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Avax Technologies Basic Information, Manufacturing Base and Competitors
Table Avax Technologies Emerging Cancer Vaccines Type and Applications
Table Avax Technologies Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Emerging Cancer Vaccines Type and Applications
Table GlaxoSmithKline Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Emerging Cancer Vaccines Type and Applications
Table Merck Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Moderna Basic Information, Manufacturing Base and Competitors
Table Moderna Emerging Cancer Vaccines Type and Applications
Table Moderna Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table Northwest Biotherapeutics Emerging Cancer Vaccines Type and Applications
Table Northwest Biotherapeutics Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Emerging Cancer Vaccines Sales by Manufacturer (2017-2018)
Figure Global Emerging Cancer Vaccines Sales Market Share by Manufacturer in 2017
Figure Global Emerging Cancer Vaccines Sales Market Share by Manufacturer in 2018
Table Global Emerging Cancer Vaccines Revenue by Manufacturer (2017-2018)
Figure Global Emerging Cancer Vaccines Revenue Market Share by Manufacturer in 2017
Figure Global Emerging Cancer Vaccines Revenue Market Share by Manufacturer in 2018
Figure Top 3 Emerging Cancer Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Emerging Cancer Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Global Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Global Emerging Cancer Vaccines Revenue and Growth Rate (2014-2019)
Table Global Emerging Cancer Vaccines Sales by Regions (2014-2019)
Table Global Emerging Cancer Vaccines Sales Market Share by Regions (2014-2019)
Table Global Emerging Cancer Vaccines Revenue by Regions (2014-2019)
Figure Global Emerging Cancer Vaccines Revenue Market Share by Regions in 2014
Figure Global Emerging Cancer Vaccines Revenue Market Share by Regions in 2018
Figure North America Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure South America Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure North America Emerging Cancer Vaccines Revenue and Growth Rate (2014-2019)
Table North America Emerging Cancer Vaccines Sales by Countries (2014-2019)
Table North America Emerging Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure North America Emerging Cancer Vaccines Sales Market Share by Countries in 2014
Figure North America Emerging Cancer Vaccines Sales Market Share by Countries in 2018
Table North America Emerging Cancer Vaccines Revenue by Countries (2014-2019)
Table North America Emerging Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Emerging Cancer Vaccines Revenue Market Share by Countries in 2014
Figure North America Emerging Cancer Vaccines Revenue Market Share by Countries in 2018
Figure United States Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Canada Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Mexico Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Emerging Cancer Vaccines Revenue and Growth Rate (2014-2019)
Table Europe Emerging Cancer Vaccines Sales by Countries (2014-2019)
Table Europe Emerging Cancer Vaccines Sales Market Share by Countries (2014-2019)
Table Europe Emerging Cancer Vaccines Revenue by Countries (2014-2019)
Figure Europe Emerging Cancer Vaccines Revenue Market Share by Countries in 2017
Figure Europe Emerging Cancer Vaccines Revenue Market Share by Countries in 2018
Figure Germany Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure UK Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure France Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Russia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Italy Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Emerging Cancer Vaccines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Emerging Cancer Vaccines Sales by Countries (2014-2019)
Table Asia-Pacific Emerging Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Emerging Cancer Vaccines Sales Market Share by Countries 2018
Table Asia-Pacific Emerging Cancer Vaccines Revenue by Countries (2014-2019)
Figure Asia-Pacific Emerging Cancer Vaccines Revenue Market Share by Countries 2018
Figure China Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Japan Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Korea Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure India Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Southeast Asia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure South America Emerging Cancer Vaccines Revenue and Growth Rate (2014-2019)
Table South America Emerging Cancer Vaccines Sales by Countries (2014-2019)
Table South America Emerging Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure South America Emerging Cancer Vaccines Sales Market Share by Countries in 2018
Table South America Emerging Cancer Vaccines Revenue by Countries (2014-2019)
Table South America Emerging Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Emerging Cancer Vaccines Revenue Market Share by Countries in 2018
Figure Brazil Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Argentina Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Colombia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Emerging Cancer Vaccines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Emerging Cancer Vaccines Sales by Countries (2014-2019)
Table Middle East and Africa Emerging Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Emerging Cancer Vaccines Sales Market Share by Countries in 2018
Table Middle East and Africa Emerging Cancer Vaccines Revenue by Countries (2014-2019)
Table Middle East and Africa Emerging Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Emerging Cancer Vaccines Revenue Market Share by Countries in 2014
Figure Middle East and Africa Emerging Cancer Vaccines Revenue Market Share by Countries in 2018
Figure Saudi Arabia Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure UAE Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Egypt Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure Nigeria Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Figure South Africa Emerging Cancer Vaccines Sales and Growth Rate (2014-2019)
Table Global Emerging Cancer Vaccines Sales by Type (2014-2019)
Table Global Emerging Cancer Vaccines Sales Share by Type (2014-2019)
Table Global Emerging Cancer Vaccines Revenue by Type (2014-2019)
Table Global Emerging Cancer Vaccines Revenue Share by Type (2014-2019)
Figure Global Non Genetic Vaccines Sales Growth (2014-2019)
Figure Global Non Genetic Vaccines Price (2014-2019)
Figure Global Genetic Vaccines Sales Growth (2014-2019)
Figure Global Genetic Vaccines Price (2014-2019)
Table Global Emerging Cancer Vaccines Sales by Application (2014-2019)
Table Global Emerging Cancer Vaccines Sales Share by Application (2014-2019)
Figure Global Cancer Hospital Sales Growth (2014-2019)
Figure Global Clinics Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Emerging Cancer Vaccines Sales, Revenue and Growth Rate (2019-2024)
Table Global Emerging Cancer Vaccines Sales Forecast by Regions (2019-2024)
Table Global Emerging Cancer Vaccines Market Share Forecast by Regions (2019-2024)
Figure North America Sales Emerging Cancer Vaccines Market Forecast (2019-2024)
Figure Europe Sales Emerging Cancer Vaccines Market Forecast (2019-2024)
Figure Asia-Pacific Sales Emerging Cancer Vaccines Market Forecast (2019-2024)
Figure South America Sales Emerging Cancer Vaccines Market Forecast (2019-2024)
Figure Middle East and Africa Sales Emerging Cancer Vaccines Market Forecast (2019-2024)
Table Global Emerging Cancer Vaccines Sales Forecast by Type (2019-2024)
Table Global Emerging Cancer Vaccines Market Share Forecast by Type (2019-2024)
Table Global Emerging Cancer Vaccines Sales Forecast by Application (2019-2024)
Table Global Emerging Cancer Vaccines Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

以下、関連資料のご紹介

世界の新興癌ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Emerging Cancer Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F0989 2019年11月11日 123Pages
本調査レポートは、新興癌ワクチンの世界市場について調べ、まとめました。種類別セグメントは、非遺伝子ワクチン、遺伝子ワクチン等、用途別セグメントは、がん研究センター、がん病院、クリニック、その他等に区分しました。新興癌ワクチンの世界市場概観、メーカー動向、メーカー別新興癌ワクチンシェア、市場規模推移、...

世界のRNAワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global RNA Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F2143 2019年11月4日 123Pages
本調査レポートは、RNAワクチンの世界市場について調べ、まとめました。種類別セグメントは、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン等、用途別セグメントは、感染症、がん、その他等に区分しました。RNAワクチンの世界市場概観、メーカー動向、メーカー別RNAワクチ...

世界の猫用ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Cat Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F0625 2019年11月4日 122Pages
本調査レポートは、猫用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、＜6ヶ月、≥6ヶ月等に区分しました。猫用ワクチンの世界市場概...

世界の犬用ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Dog Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F0888 2019年11月4日 121Pages
本調査レポートは、犬用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、<6か月、≥か月等に区分しました。犬用ワクチンの世界市場概観...

世界の小児ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Childhood Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F0672 2019年11月14日 106Pages
本調査レポートは、小児ワクチンの世界市場について調べ、まとめました。種類別セグメントは、組換えワクチン、ウイルスワクチン、多糖ワクチン、その他等、用途別セグメントは、病院、クリニック等に区分しました。小児ワクチンの世界市場概観、メーカー動向、メーカー別小児ワクチンシェア、市場規模推移、市場規模予測（...

世界の小児ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

世界のオーエスキー病ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Aujeszky Disease Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F0314 2019年11月14日 100Pages
本調査レポートは、オーエスキー病ワクチンの世界市場について調べ、まとめました。種類別セグメントは、凍結乾燥錠、注射剤等、用途別セグメントは、雌ブタ、子ブタ、イノシシ等に区分しました。オーエスキー病ワクチンの世界市場概観、メーカー動向、メーカー別オーエスキー病ワクチンシェア、市場規模推移、市場規模予測...

世界のオーエスキー病ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

世界のパーソナライズ癌医学市場予測（～2024年）

Global Personalized Cancer Medicine Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4193 2019年9月18日 116Pages
本調査レポートは、パーソナライズ癌医学の世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、個別化癌ワクチン、その他等、用途別セグメントは、乳癌、肺癌、慢性骨髄性白血病、腸癌、その他癌等に区分しました。パーソナライズ癌医学の世界市場概観、企業動向、企業別パーソナライズ癌医学シ...

世界のトキソイドワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Toxoid Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F2465 2019年11月4日 119Pages
本調査レポートは、トキソイドワクチンの世界市場について調べ、まとめました。種類別セグメントは、一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリアおよび破傷風（DT）等、用途別セグメントは、病院および診療所、政府機関、研究、その他等に区分しました。トキソイドワクチンの世界...

世界の新興癌ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別 Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens. Scope of the Report: The worldwide market for Emerging Cancer Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, fro…
世界のRNAワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別 RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which …
世界のパーソナライズ癌医学市場予測（～2024年） Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors c…
世界の小児ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Childhood Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Childhood Vaccines i…
世界の小児ワクチン市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Childhood Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Childhood Vaccines i…